Skip to content

Systematic review, 2024

Do SSRI antidepressants help treat PMS and PMDD?

Yes. SSRIs probably reduce premenstrual symptoms in women with PMS and PMDD based on moderate-certainty evidence from 34 studies. Daily continuous use appears more effective than taking SSRIs only before your period.

Strong study design 3,722 women with prospective diagnosis of PMS, PMDD, or late luteal phase dysphoric disorder across 34 studies

What they did

Cochrane systematic review of 34 randomized controlled trials comparing five types of SSRIs (fluoxetine, paroxetine, sertraline, escitalopram, and citalopram) to placebo in women with PMS or PMDD. Analyzed whether continuous daily use or use only during the luteal phase (the two weeks before menstruation) was more effective.

What they found

SSRIs reduced overall premenstrual symptoms in 1,742 women with moderate-certainty evidence. Continuous daily SSRI use was probably more effective than using SSRIs only during the luteal phase.

What it means for you

SSRIs can help reduce PMS and PMDD symptoms, with daily continuous use appearing more effective than intermittent use only before your period. This finding is based on good evidence from many studies. The main limitation is that the abstract does not fully detail the adverse effects or long-term safety of SSRIs.

3722

total women studied

34

randomized controlled trials

1742

women in main analysis

About the study

Original title
Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder
Authors
Jespersen C, Lauritsen MP, Frokjaer VG et al.
Journal
The Cochrane database of systematic reviews
Year
2024
Study design
Systematic review
What was tested
SSRIs (fluoxetine, paroxetine, sertraline, escitalopram, citalopram), continuous or luteal-phase use
Open access
Yes

Topics